MMHW Medical Weight Management

06/21/2023

Did you know the FDA approved certain Semaglutide products for weight management in 2021?

Studies have shown 15% body mass reduction through the use of Semaglutide.

Thousands of Americans have successfully used it to support healthy and sustainable weight loss.

Take our quiz now to see if it might be appropriate for you too:

05/29/2023

Novo says oral version of Ozempic leads to 15% weight loss

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

read more:

Adding an oral option of Ozempic and Wegovy would give Novo Nordisk “the first safe, highly efficacious weight-loss pill ever marketed,” an analyst noted.

05/29/2023

Welcome to MMHW Medical Weight Management!

We make your health the priority. With over 80 years of combined expertise in the health industry, our doctors,
nurses and care providers will make you feel youthful and well once again. We prioritize our clients’ health and happiness.